“…In patients with trauma, 3 patients undergoing cardiac surgery, 4 and even patients with critical illness, 5,6 single-dose etomidate for induction of anesthesia showed no difference in mortality compared with other agents, whereas the influence of etomidate on morbidity, such as hospital-acquired pneumonia, remains controversial. 4,[7][8][9] Furthermore, because most studies have focused on bolus administration of etomidate for anesthesia induction, there is a lack of data on the effects of continuous infusion of etomidate for anesthesia maintenance on hemodynamics, adrenocortical suppression, and clinical outcomes.…”